We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$778M
AUM Growth
-$1.85M
Cap. Flow
-$35.3M
Cap. Flow %
-4.54%
Top 10 Hldgs %
34.42%
Holding
5,522
New
919
Increased
1,531
Reduced
1,579
Closed
1,330

Sector Composition

Rank Sector Weight
1 Industrials 6%
2 Financials 5.45%
3 Technology 5.24%
4 Consumer Discretionary 4.75%
5 Healthcare 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETX
3501
DELISTED
Aratana Therapeutics, Inc.
PETX
$2K ﹤0.01%
111
-2,075
-95% -$29.4K
BORN
3502
DELISTED
China New Borun Corporation
BORN
$2K ﹤0.01%
+828
New +$2.27K
TFCFA
3503
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$2K ﹤0.01%
+58
New +$1.97K
CYHHZ
3504
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
26,403
PERY
3505
DELISTED
Perry Ellis International Inc
PERY
$2K ﹤0.01%
96
-1,524
-94% -$24.1K
ILG
3506
DELISTED
ILG, Inc Common Stock
ILG
$2K ﹤0.01%
77
-1,217
-94% -$28.1K
SIGM
3507
DELISTED
Sigma Designs Inc
SIGM
$2K ﹤0.01%
343
-47
-12% -$189
XPLR
3508
DELISTED
Xplore Technologies Corp.
XPLR
$2K ﹤0.01%
370
-773
-68% -$4.58K
BPFHP
3509
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
$2K ﹤0.01%
79
+10
+14% +$242
ENZY
3510
DELISTED
Enzymotec Ltd
ENZY
$2K ﹤0.01%
130
-198
-60% -$3.33K
RLOG
3511
DELISTED
Rand Logistics, Inc.
RLOG
$2K ﹤0.01%
331
-14
-4% -$87
FIG
3512
DELISTED
Fortress Investment Group Llc
FIG
$2K ﹤0.01%
321
+263
+453% +$1.92K
OME
3513
DELISTED
Omega Protein
OME
$2K ﹤0.01%
164
-210
-56% -$2.75K
BONT
3514
DELISTED
Bon-Ton Stores Inc/The
BONT
$2K ﹤0.01%
207
-6
-3% -$64
PKY
3515
DELISTED
Parkway, Inc.
PKY
$2K ﹤0.01%
+100
New +$1.94K
RNVA
3516
DELISTED
Rennova Health, Inc.
RNVA
0
COVS
3517
DELISTED
Covisint Corporation
COVS
$2K ﹤0.01%
393
-98
-20% -$613
XRDC
3518
DELISTED
Crossroads Capital, Inc
XRDC
$2K ﹤0.01%
+298
New +$1.84K
JIVE
3519
DELISTED
Jive Software, Inc.
JIVE
$2K ﹤0.01%
192
-2,227
-92% -$17.6K
INVN
3520
DELISTED
Invensense Inc
INVN
$2K ﹤0.01%
100
-804
-89% -$16.4K
ERS
3521
DELISTED
Empire Resources, Inc.
ERS
$2K ﹤0.01%
521
-638
-55% -$2.62K
XXIA
3522
DELISTED
Ixia
XXIA
$2K ﹤0.01%
+175
New +$2.14K
MEET
3523
DELISTED
The Meet Group, Inc. Common Stock
MEET
$2K ﹤0.01%
+917
New +$2.29K
JOY
3524
DELISTED
Joy Global Inc
JOY
$2K ﹤0.01%
30
-2,889
-99% -$174K
VASC
3525
DELISTED
Vascular Solutions Inc
VASC
$2K ﹤0.01%
89
-1,424
-94% -$31.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2014 Portfolio in Review

As of Q2 2014, Tower Research Capital (TRC) held 5,522 positions worth $778M, down 0.24% from $780M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $35.3M in Q2 2014, closing 1,330 positions and reducing 1,579 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $9.03M.

  • Tower Research Capital (TRC)'s largest Q2 2014 buy was iShares Russell 1000 Value ETF: 89,185 shares worth $9.03M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $177M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2014 reduction was Invesco QQQ Trust, cutting an estimated $110M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Small-Cap ETF in Q2 2014, selling an estimated $10.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $778M portfolio in Q2 2014.
  • Tower Research Capital (TRC) opened 919 new positions and closed 1,330 in Q2 2014.
  • Tower Research Capital (TRC)'s portfolio value fell 0.24% quarter-over-quarter to $778M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.